Please enable JavaScript to continue using this application.

Compare $IBIO vs $KLRS | Chartloom

Compare

$IBIO vs $KLRS

iBio Inc · Kalaris Therapeutics Inc

IBIO

iBio Inc

KLRS

Kalaris Therapeutics Inc

Compare $IBIO vs $KLRS

Comparing iBio Inc and Kalaris Therapeutics Inc

IBIOiBio Inc

KLRSKalaris Therapeutics Inc

IBIOiBio Inc

Market cap

$43M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-75.0%

YTD performance

-56.9%

52W performance

0.5%

FCF yield

-55.0%

KLRSKalaris Therapeutics Inc

Market cap

$56M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-71.6%

52W performance

-64.2%

FCF yield

-73.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IBIO

KLRS

Detailed metrics comparison

IBIO

iBio Inc

KLRS

Kalaris Therapeutics Inc

Market Cap

IBIO$43M

KLRS$56M

Enterprise Value

IBIO$-13M

KLRS$45M

Price

IBIO$0.87

KLRS$2.36

P/E Ratio

IBION/A

KLRSN/A

P/S Ratio

IBIO432.71x

KLRS0.00x

EV/Sales

IBIO-131.24x

KLRS0.00x

EV/EBITDA

IBIO0.00x

KLRS0.00x

P/B Ratio

IBIO0.80x

KLRS1.02x

P/FCF Ratio

IBION/A

KLRSN/A

EV/FCF

IBIO0.55x

KLRS-1.09x

PEG Ratio

IBION/A

KLRSN/A

Forward P/E (NTM)

IBION/A

KLRSN/A

Forward P/S (NTM)

IBION/A

KLRSN/A

Revenue (TTM)

IBIO$100K

KLRS$0

Revenue Growth (YoY)

IBIO-75.0%

KLRSN/A

Forward Rev Growth

IBIO33.3%

KLRS180.3%

Gross Margin (TTM)

IBIO52.1%

KLRS0.0%

Operating Margin (TTM)

IBIO0.0%

KLRS0.0%

EBITDA Margin (TTM)

IBIO-24492.0%

KLRS0.0%

Net Margin (TTM)

IBIO-33044.0%

KLRS0.0%

FCF Margin (TTM)

IBIO-23796.0%

KLRSN/A

Net Income (TTM)

IBIO$-33M

KLRS$-44M

FCF (TTM)

IBIO$-24M

KLRS$-41M

EPS (TTM)

IBIO-$0.23

KLRS-$1.86

ROE (TTM)

IBIO-4792.0%

KLRS-7171.0%

ROA (TTM)

IBIO-4216.0%

KLRS-4295.0%

ROIC (TTM)

IBIO-4779.0%

KLRS-4719.0%

Cash

IBIO$56M

KLRS$43M

Debt

IBIO$0

KLRS$32M

Net Cash/Debt

IBIO$56M

KLRS$11M

Current Ratio (TTM)

IBIO7.85x

KLRS10.98x

Quick Ratio (TTM)

IBIO7.59x

KLRS10.76x

Debt/Equity (TTM)

IBIO0.91x

KLRS0.56x

Debt/Assets (TTM)

IBIO0.0%

KLRS0.0%

Interest Coverage (TTM)

IBION/A

KLRSN/A

Net Debt/EBITDA (TTM)

IBIO0.00x

KLRS0.00x

Beta

IBIO1.42

KLRS0.44

52W Performance

IBIO0.5%

KLRS-64.2%

YTD Performance

IBIO-56.9%

KLRS-71.6%

% from 52W High

IBIO-77.2%

KLRS-80.1%

% from 52W Low

IBIO11.5%

KLRS0.4%

Asset Turnover (TTM)

IBIO0.01x

KLRS0.00x

FCF Yield (TTM)

IBIO-55.0%

KLRS-73.4%

Earnings Yield (TTM)

IBIO-76.4%

KLRS-78.8%

Dividend Yield (TTM)

IBION/A

KLRSN/A

Rule of 40

IBIO-23,871.0

KLRS0.0

EV/GP/RG

IBION/A

KLRSN/A

Ticker research

View IBIO research View KLRS research

Metric	IBIO iBio Inc	KLRS Kalaris Therapeutics Inc
Market & Valuation
Market Cap	$43M	$56M
Enterprise Value	$-13M	$45M
Price	$0.87	$2.36
P/E Ratio	N/A	N/A
P/S Ratio	432.71x	0.00x
EV/Sales	-131.24x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.80x	1.02x
P/FCF Ratio	N/A	N/A
EV/FCF	0.55x	-1.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$100K	$0
Revenue Growth (YoY)	-75.0%	N/A
Forward Rev Growth	33.3%	180.3%
Profitability
Gross Margin (TTM)	52.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-24492.0%	0.0%
Net Margin (TTM)	-33044.0%	0.0%
FCF Margin (TTM)	-23796.0%	N/A
Net Income (TTM)	$-33M	$-44M
FCF (TTM)	$-24M	$-41M
EPS (TTM)	-$0.23	-$1.86
ROE (TTM)	-4792.0%	-7171.0%
ROA (TTM)	-4216.0%	-4295.0%
ROIC (TTM)	-4779.0%	-4719.0%
Financial Health
Cash	$56M	$43M
Debt	$0	$32M
Net Cash/Debt	$56M	$11M
Current Ratio (TTM)	7.85x	10.98x
Quick Ratio (TTM)	7.59x	10.76x
Debt/Equity (TTM)	0.91x	0.56x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.42	0.44
52W Performance	0.5%	-64.2%
YTD Performance	-56.9%	-71.6%
% from 52W High	-77.2%	-80.1%
% from 52W Low	11.5%	0.4%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-55.0%	-73.4%
Earnings Yield (TTM)	-76.4%	-78.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-23,871.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IBIO research	View KLRS research

Valuation

P/S Ratio

KLRS

0.00x

IBIO

432.71x

EV/FCF

KLRS

-1.09x

IBIO

0.55x

Growth & revenue

Revenue Growth TTM

IBIO

-75.0%

Forward Revenue Growth

KLRS

180.3%

IBIO

33.3%

Profitability & performance

Gross Margin

IBIO

52.1%

KLRS

0.0%

ROE

IBIO

-4792.0%

KLRS

-7171.0%

FCF Yield %

IBIO

-55.0%

KLRS

-73.4%

52-Week Performance

IBIO

0.5%

KLRS

-64.2%

Detailed metrics comparison

IBIO

iBio Inc

KLRS

Kalaris Therapeutics Inc

Market Cap

IBIO$43M

KLRS$56M

Enterprise Value

IBIO$-13M

KLRS$45M

Price

IBIO$0.87

KLRS$2.36

P/E Ratio

IBION/A

KLRSN/A

P/S Ratio

IBIO432.71x

KLRS0.00x

EV/Sales

IBIO-131.24x

KLRS0.00x

EV/EBITDA

IBIO0.00x

KLRS0.00x

P/B Ratio

IBIO0.80x

KLRS1.02x

P/FCF Ratio

IBION/A

KLRSN/A

EV/FCF

IBIO0.55x

KLRS-1.09x

PEG Ratio

IBION/A

KLRSN/A

Forward P/E (NTM)

IBION/A

KLRSN/A

Forward P/S (NTM)

IBION/A

KLRSN/A

Revenue (TTM)

IBIO$100K

KLRS$0

Revenue Growth (YoY)

IBIO-75.0%

KLRSN/A

Forward Rev Growth

IBIO33.3%

KLRS180.3%

Gross Margin (TTM)

IBIO52.1%

KLRS0.0%

Operating Margin (TTM)

IBIO0.0%

KLRS0.0%

EBITDA Margin (TTM)

IBIO-24492.0%

KLRS0.0%

Net Margin (TTM)

IBIO-33044.0%

KLRS0.0%

FCF Margin (TTM)

IBIO-23796.0%

KLRSN/A

Net Income (TTM)

IBIO$-33M

KLRS$-44M

FCF (TTM)

IBIO$-24M

KLRS$-41M

EPS (TTM)

IBIO-$0.23

KLRS-$1.86

ROE (TTM)

IBIO-4792.0%

KLRS-7171.0%

ROA (TTM)

IBIO-4216.0%

KLRS-4295.0%

ROIC (TTM)

IBIO-4779.0%

KLRS-4719.0%

Cash

IBIO$56M

KLRS$43M

Debt

IBIO$0

KLRS$32M

Net Cash/Debt

IBIO$56M

KLRS$11M

Current Ratio (TTM)

IBIO7.85x

KLRS10.98x

Quick Ratio (TTM)

IBIO7.59x

KLRS10.76x

Debt/Equity (TTM)

IBIO0.91x

KLRS0.56x

Debt/Assets (TTM)

IBIO0.0%

KLRS0.0%

Interest Coverage (TTM)

IBION/A

KLRSN/A

Net Debt/EBITDA (TTM)

IBIO0.00x

KLRS0.00x

Beta

IBIO1.42

KLRS0.44

52W Performance

IBIO0.5%

KLRS-64.2%

YTD Performance

IBIO-56.9%

KLRS-71.6%

% from 52W High

IBIO-77.2%

KLRS-80.1%

% from 52W Low

IBIO11.5%

KLRS0.4%

Asset Turnover (TTM)

IBIO0.01x

KLRS0.00x

FCF Yield (TTM)

IBIO-55.0%

KLRS-73.4%

Earnings Yield (TTM)

IBIO-76.4%

KLRS-78.8%

Dividend Yield (TTM)

IBION/A

KLRSN/A

Rule of 40

IBIO-23,871.0

KLRS0.0

EV/GP/RG

IBION/A

KLRSN/A

Ticker research

View IBIO research View KLRS research

Metric	IBIO iBio Inc	KLRS Kalaris Therapeutics Inc
Market & Valuation
Market Cap	$43M	$56M
Enterprise Value	$-13M	$45M
Price	$0.87	$2.36
P/E Ratio	N/A	N/A
P/S Ratio	432.71x	0.00x
EV/Sales	-131.24x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.80x	1.02x
P/FCF Ratio	N/A	N/A
EV/FCF	0.55x	-1.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$100K	$0
Revenue Growth (YoY)	-75.0%	N/A
Forward Rev Growth	33.3%	180.3%
Profitability
Gross Margin (TTM)	52.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-24492.0%	0.0%
Net Margin (TTM)	-33044.0%	0.0%
FCF Margin (TTM)	-23796.0%	N/A
Net Income (TTM)	$-33M	$-44M
FCF (TTM)	$-24M	$-41M
EPS (TTM)	-$0.23	-$1.86
ROE (TTM)	-4792.0%	-7171.0%
ROA (TTM)	-4216.0%	-4295.0%
ROIC (TTM)	-4779.0%	-4719.0%
Financial Health
Cash	$56M	$43M
Debt	$0	$32M
Net Cash/Debt	$56M	$11M
Current Ratio (TTM)	7.85x	10.98x
Quick Ratio (TTM)	7.59x	10.76x
Debt/Equity (TTM)	0.91x	0.56x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.42	0.44
52W Performance	0.5%	-64.2%
YTD Performance	-56.9%	-71.6%
% from 52W High	-77.2%	-80.1%
% from 52W Low	11.5%	0.4%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-55.0%	-73.4%
Earnings Yield (TTM)	-76.4%	-78.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-23,871.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IBIO research	View KLRS research